Citation Impact
Citing Papers
Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?
2007
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score
2014
Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study
2015
Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
2012
The impact of the HEART risk score in the early assessment of patients with acute chest pain: design of a stepped wedge, cluster randomised trial
2013
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
Advanced Age, Antithrombotic Strategy, and Bleeding in Non–ST-Segment Elevation Acute Coronary Syndromes
2009
Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score
2011
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
2009
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study
2005
Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort
2004
Chest Pain in the Emergency Room
2010
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
2006
Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry
2010
Acute Coronary Syndrome
2010
Revisiting comorbidities in gout: a cluster analysis
2013
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Ulcerative Colitis
2011 Standout
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
2017
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
2013
“Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?”
2010
The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department
2010
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
2011
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores
2009
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Delirium in Elderly Patients and the Risk of Postdischarge Mortality, Institutionalization, and Dementia
2010 Standout
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
2009
Systematic review: the costs of ulcerative colitis in Western countries
2010
Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
2011
Phospholipase A2s: Developing drug targets for atherosclerosis
2010
Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study
2009
Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study
2010
Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Case–Control Study
2010
New Antithrombotic Drugs
2012
Extracellular phospholipases in atherosclerosis
2010
A study to derive a clinical decision rule for triage of emergency department patients with chest pain: design and methodology
2008
Impact of Delay to Angioplasty in Patients With Acute Coronary Syndromes Undergoing Invasive Management
2010
The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide
2011
Health-related quality of life in gout: a systematic review
2013
Determinants and outcomes of coronary angiography after non-ST-segment elevation myocardial infarction. A cohort study of the Myocardial Ischaemia National Audit Project (MINAP)
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
The Year in Non-ST-Segment Elevation Acute Coronary Syndromes
2005
One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis
2007
CORONARY REVASCULARISATION IN CHRONIC KIDNEY DISEASE PART II: ACUTE CORONARY SYNDROMES
2010
Revascularization for heart failure
2007
Arrhythmia Risk Stratification with Regard to Prophylactic Implantable Defibrillator Therapy in Patients with Dilated Cardiomyopathy
2004
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study
2007
Prognostic Value of Mid-Regional Pro-Adrenomedullin Levels Taken on Admission and Discharge in Non–ST-Elevation Myocardial Infarction
2010
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
2008
Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database
2008
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
2013 StandoutNobel
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
An examination of clinical intuition in risk assessment among acute coronary syndromes patients: Observations from a prospective multi-center international observational registry
2013
Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2010
TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS
2005
Recent Trends in the Care of Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
2006
Influence of Age on Use of Cardiac Catheterization and Associated Outcomes in Patients With Non-ST-Elevation Acute Coronary Syndromes
2009
Association Between Timeliness of Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial Infarction
2010
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients
2012
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 Standout
Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes
2009
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
2009
Diabetes in Asia
2009 Standout
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial
2008
Usefulness of Changes in Fasting Glucose During Hospitalization to Predict Long-Term Mortality in Patients With Acute Myocardial Infarction
2009
Antiplatelet Drugs
2012
Metabolic syndrome, diabetes, and hyperuricemia
2013
Antiplatelet Drugs
2008
New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs
2010
Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry
2008
Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials
2010
Potential survival gains in the treatment of myocardial infarction
2009
Sex Versus Gender-Related Characteristics
2016
Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis
2018
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events
2007
Gout
2016 Standout
Myocarditis
2011 Standout
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome
2006
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
2005
Acne vulgaris
2011 Standout
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome
2016
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era
2010
Diabetes and Mortality Following Acute Coronary Syndromes
2007
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: Insights from American Heart Association's Get With the Guidelines program
2008
Clopidogrel–Drug Interactions
2011
Association of prior coronary artery bypass graft surgery with quality of care of patients with non–ST-segment elevation myocardial infarction: A report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines
2010
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society
2009
Guidelines for Percutaneous Coronary Interventions
2005
Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)
2008
Ulcerative colitis
2016 Standout
A Simplified Approach to the Management of Non–ST-Segment Elevation Acute Coronary Syndromes
2005
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
2010
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
2010
Early versus Delayed Invasive Intervention in Acute Coronary Syndromes
2009
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
Risk scores in acute coronary syndrome and percutaneous coronary intervention: A review
2013
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Improving long-term risk prediction in patients with acute chest pain: The Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers
2010
Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
2008
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk
2009
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
2013
Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects
2008
Validity of a risk-prediction tool for hospital mortality: The Global Registry of Acute Coronary Events
2009
Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)
2006
Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction
2005
Chest pain presenting to the Emergency Department—to stratify risk with GRACE or TIMI?
2007
Sarcoidosis
2007 Standout
Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
2006
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial
2006
Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry
2012
Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010
2011
Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance
2010
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE
2010
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events
2005
Impact of Acute Beta-Blocker Therapy for Patients with Non–ST-Segment Elevation Myocardial Infarction
2007
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
2015
Procedural and long-term outcome of primary percutaneous coronary intervention in octogenarians
2010
The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: Molecular mechanisms and clinical implications
2012
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Age, treatment, and outcomes in high-risk non‐ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial
2012
Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes
2013
Culprit-only or multivessel revascularization in patients with acute coronary syndromes
2007
Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes
2006
Incidence of heart failure and mortality after acute coronary syndromes
2013
Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20)
2014
Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values
2007
Myocarditis
2009 Standout
Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
2004
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure
2010
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Cardiogenic Shock
2008
Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome
2011
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization
2012
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study
2010
Statistical Models and Patient Predictors of Readmission for Acute Myocardial Infarction
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes
2016
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Acute Myocardial Infarction in Women
2016
Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes
2005
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Mendelian randomisation applied to drug development in cardiovascular disease: a review
2014
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Impact of Early Coronary Artery Bypass Graft in an Unselected Acute Coronary Syndrome Patient Population
2006
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction
2011
Oxygen therapy for acute myocardial infarction
2016
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Management Patterns in Relation to Risk Stratification Among Patients With Non–ST Elevation Acute Coronary Syndromes
2007
Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice
2010
Gout
2021 Standout
Incremental Prognostic Value of Biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) Score and High-Sensitivity Cardiac Troponin T in Non-ST-Elevation Acute Coronary Syndrome
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients
2013
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Patient–physician gender concordance and increased mortality among female heart attack patients
2018 Standout
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
2006
One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database
2008
Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes<subtitle>The Hong Kong Diabetes Registry</subtitle>
2008
Renal excretion is a cause of decreased serum uric acid during acute gout
2018
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes
2007
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
2008
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction
2009
Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
2009
Periprocedural Stroke and Cardiac Catheterization
2008
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.
2013
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Omar Dabbous being referenced
Chronic kidney disease in gout in a managed care setting
2011
Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study
2011
Administrative Claims Analysis of All-Cause Annual Costs of Care and Resource Utilization by Age Category for Ulcerative Colitis Patients
2008
Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events
2007
Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)
2006
In-Hospital Revascularization and One-Year Outcome of Acute Coronary Syndrome Patients Stratified by the GRACE Risk Score
2005
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study
2003
Patterns of use and potential impact of early β-blocker therapy in non–ST-elevation myocardial infarction with and without heart failure: The Global Registry of Acute Coronary Events
2006
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
2003
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
2006
Relation of Timing of Cardiac Catheterization to Outcomes in Patients With Non–ST-Segment Elevation Myocardial Infarction or Unstable Angina Pectoris Enrolled in the Multinational Global Registry of Acute Coronary Events
2005
Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (The Global Registry of Acute Coronary Events [GRACE])
2004
Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery
2006
Medication performance measures and mortality following acute coronary syndromes
2005
Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, and Diabetes: A 15-Year Follow-up Study
2012
Use of proven therapies in non–ST-elevation acute coronary syndromes according to evidence-based risk stratification
2007
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry
2005
Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes
2005
A Validated Prediction Model for All Forms of Acute Coronary Syndrome
2004
Health Care Expenditures in Ulcerative Colitis: The Perspective of a Self-Insured Employer
2008
Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation
2003
Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction
2012
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)
2007
Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10
2011
Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes
2007
Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes
2004
Predictors of hospital mortality in the global registry of acute coronary events
2004
Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings
2011
T1142 Infliximab Treatment for Ulcerative Colitis: Clinical Response, Clinical Remission, & Mucosal Healing in Patients with Moderate or Severe Disease in the Active Ulcerative Colitis Trials (ACT1 & ACT2)
2008
Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes
2005